Age-related Macular Degeneration
Convenor: Kgaogelo Edward Moleke Legodi
Age-related macular degeneration (AMD), while traditionally recognised as a less common condition due to its appearance in old age, is becoming more common as medical advances are resulting in longer lifespans and is responsible for 7% of global blindness in 2010. It predominates over most causes of blindness in developed countries. Much research has gone into the investigation of risk factors, nutrition and treatment of the condition.
This course will look at the pathophysiology, risk factors and clinical investigation of AMD. It will highlight the key issues related to the diagnosis and treatment of dry and wet AMD. It will also look at the challenges of maintaining vision in AMD patients as it highlights recent research on treatment strategies.
- To discuss the risk factors involved in AMD
- To define the pathophysiological process involved in the development of AMD
- To outline the clinical investigation used to diagnose AMD
- To discuss the developments in treatment of AMD
|Ogugua Ndubuisi Okonkwo||AMD diagnosis and treatment: past, present and future|
|Kunle Hassan||Risk factors for AMD|
|Olufemi Oderinlo||Pathophysiology, risk factors and clinical investigation of the AMD patient|
Spread the word on social media
Use the hash tags –
I’m attending the #10GA course 28 on age-related macular degeneration – Tweet this